RHAMM(B)-mediated bifunctional nanotherapy targeting Bcl-xL and mitochondria for pancreatic neuroendocrine tumor treatment

The incidence of pancreatic neuroendocrine tumor (PNET) has continued to rise. Due to their indolent feature, PNET patients often present with incurable, metastatic diseases. Novel therapies are urgently needed. We have previously shown that Receptor for Hyaluronic Acid-Mediated Motility isoform B (...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiang, Lee, Seung Koo, Song, Mei, Zhang, Tiantian, Han, Myung Shin, Chen, Yao-Tseng, Chen, Zhengming, Ma, Xiaojing, Tung, Ching-Hsuan, Du, Yi-Chieh Nancy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560716/
https://www.ncbi.nlm.nih.gov/pubmed/34761107
http://dx.doi.org/10.1016/j.omto.2021.10.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560716/
https://www.ncbi.nlm.nih.gov/pubmed/34761107
http://dx.doi.org/10.1016/j.omto.2021.10.002

Ejemplares similares